- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07747376
Benign Paroxysmal Positional Vertigo With and Without Vestibular Hypofunction: Protocol for an Integrated Home-Based Exercise With Self-Managed Education Programme
Development and Validation of a Home-based Exercise Programme Integrated With a Self-managed Education Programme in People With Benign Paroxysmal Positional Vertigo With and Without Vestibular Hypofunction
The goal of this feasibility pilot randomised controlled trial is to determine whether a home-based exercise programme integrated with a self-managed education programme is feasible, acceptable, and safe for adults aged 60 years and older with benign paroxysmal positional vertigo (BPPV) with and without vestibular hypofunction. The study will also evaluate whether the trial procedures are suitable for a future definitive randomised controlled trial.
The main questions it aims to answer are:
Can participants follow the programme as planned? Can participants be retained throughout the 20-week study? Is the programme acceptable to participants? Do participants experience any adverse events? Do the clinical outcomes show preliminary changes that support further investigation?
Researchers will randomly assign participants to receive either the home-based exercise and self-managed education programme or standard care alone. Preliminary changes in dizziness, balance confidence, gait performance, fall risk, physical activity, and health-related quality of life will be explored. As this is a feasibility pilot study, it is not designed to provide definitive evidence of effectiveness.
Participants will:
Take part in the study for 20 weeks Follow their assigned intervention or standard care as instructed Complete assessments at baseline, week 10, and week 20 Report their adherence, experience with the programme, and any adverse events during the study
Studieöversikt
Status
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Pulau Pinang
-
George Town, Pulau Pinang, Malaysia, 10990
- Hospital Pulau Pinang
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Diagnosed as benign paroxysmal positional vertigo by an otolaryngologist or Medical Doctor at the Ear, Nose, and Throat Clinic Hospital Pulau Pinang
- Aged 60 years and older
- Do not receive treatment from outside Hospital Pulau Pinang
Exclusion Criteria:
- Severe neurological conditions, including stroke or peripheral neuropathy
- Severe musculoskeletal disorders such as fractures, rheumatoid arthritis, or recent injuries that limit movement
- • Clinically diagnosed hearing or visual impairments
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Intervention
|
The intervention combines structured, progressive home-based exercises with a self-managed education resource.
The exercises are based on vestibular rehabilitation principles and target movement-related dizziness, gaze stability, postural balance, gait, and functional mobility.
Participants receive an illustrated booklet containing step-by-step exercise instructions, guidance on gradual progression and rest periods, and safety precautions.
Exercise progression is adapted according to the participant's functional ability and symptom response.
The education component addresses understanding of BPPV and vestibular hypofunction, safe exercise performance, symptom self-management, adherence, and when to seek professional advice.
Participants are instructed to discontinue an exercise and obtain appropriate clinical advice if severe or worsening symptoms occur.
|
|
Aktiv komparator: Standardvård
|
Standard care consists of routine clinical management for BPPV with and without vestibular hypofunction provided at the study site.
Treatment includes a canalith repositioning manoeuvre selected according to the affected semicircular canal and side, together with routine clinical advice and follow-up.
Any additional management is determined by the treating clinician according to the participant's clinical needs and usual practice at the study site.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
The Activities-specific Balance Confidence Scale
Tidsram: From enrollment to the end of treatment at 20 weeks
|
From enrollment to the end of treatment at 20 weeks
|
|
Dizziness Handicap Inventory
Tidsram: From enrollment to the end of treatment at 20 weeks
|
From enrollment to the end of treatment at 20 weeks
|
|
Dynamic Gait Index
Tidsram: From enrollment to the end of treatment at 20 weeks
|
From enrollment to the end of treatment at 20 weeks
|
|
Timed Up and Go
Tidsram: From enrollment to the end of treatment at 20 weeks
|
From enrollment to the end of treatment at 20 weeks
|
|
5 Times Sit To Stand
Tidsram: From enrollment to the end of treatment at 8 weeks
|
From enrollment to the end of treatment at 8 weeks
|
|
EQ-5D-5L
Tidsram: From enrollment to the end of treatment at 8 weeks
|
From enrollment to the end of treatment at 8 weeks
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Neurologiska manifestationer
- Sjukdomar i nervsystemet
- Otorhinolaryngologiska sjukdomar
- Öronsjukdomar
- Labyrintsjukdomar
- Vestibulära sjukdomar
- Patologiska tillstånd, tecken och symtom
- Tecken och symtom
- Vertigo
- Benign Paroxysmal Positionell Vertigo
- Administration
- Sjukvårdskvalitet, tillgång och utvärdering
- Hälsovårdskvalitet
- Kvalitetsindikatorer, hälsovård
- Vårdstandard
Andra studie-ID-nummer
- NMRR ID-25-03771-REH (IIR)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .